These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24711989)

  • 1. Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.
    Campbell LA; Rosenfeld ME
    Front Cell Infect Microbiol; 2014; 4():34. PubMed ID: 24711989
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives.
    Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P
    Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerosis: lipid infiltration or Chlamydia pneumoniae infection?
    Shor A
    Circulation; 2002 Oct; 106(18):e135-6; disscussion e135-6. PubMed ID: 12403680
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of Chlamydia pneumoniae in atherosclerosis.
    Watson C; Alp NJ
    Clin Sci (Lond); 2008 Apr; 114(8):509-31. PubMed ID: 18336368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review.
    Vainas T; Sayed S; Bruggeman CA; Stassen FR
    Drugs Today (Barc); 2009 Nov; 45 Suppl B():165-72. PubMed ID: 20011710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested.
    Grayston JT; Belland RJ; Byrne GI; Kuo CC; Schachter J; Stamm WE; Zhong G
    Pathog Dis; 2015 Feb; 73(1):1-9. PubMed ID: 25854002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae and atherosclerosis.
    Campbell LA; Kuo CC
    Semin Respir Infect; 2003 Mar; 18(1):48-54. PubMed ID: 12652454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlamydia pneumoniae-induced pathological signaling in the vasculature.
    Kern JM; Maass V; Maass M
    FEMS Immunol Med Microbiol; 2009 Mar; 55(2):131-9. PubMed ID: 19281565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice.
    Zafiratos MT; Manam S; Henderson KK; Ramsey KH; Murthy AK
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26220574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia pneumoniae in different coronary artery segments in the young.
    Hortoványi E; Illyés G; Glasz T; Kádár A
    Pathol Res Pract; 2002; 198(1):19-23. PubMed ID: 11866206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.
    Higgins JP
    Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials.
    Liu C; Waters DD
    Prog Cardiovasc Dis; 2005; 47(4):230-9. PubMed ID: 15991152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease.
    Dugan JP; Feuge RR; Burgess DS
    Clin Ther; 2002 May; 24(5):719-35. PubMed ID: 12075941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
    Campbell LA; Kuo CC
    Nat Rev Microbiol; 2004 Jan; 2(1):23-32. PubMed ID: 15035006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathology of Chlamydia pneumoniae lesions in humans and animal models.
    Shor A
    Trends Microbiol; 2000 Dec; 8(12):541-2. PubMed ID: 11201259
    [No Abstract]   [Full Text] [Related]  

  • 16. A study on immunopathogenetic mechanisms of atherosclerotic process caused by chronic infection of Chlamydia pneumoniae in rats (Ratus novergicus).
    Aziz A
    Acta Med Indones; 2006; 38(4):206-12. PubMed ID: 17132885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae and atherosclerosis.
    Hoymans VY; Bosmans JM; Ieven M; Vrints CJ
    Acta Chir Belg; 2002 Oct; 102(5):317-22. PubMed ID: 12471763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia pneumoniae infection related atherosclerotic clinical variables on carotid stenosis.
    Colpan ME; Attar A; Colpan A; Karahan C; Seckin S; Sargon MF; Egemen N
    J Clin Neurosci; 2004 May; 11(4):389-94. PubMed ID: 15080954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chlamydia pneumoniae as a pathogenetic risk factor in the development of arteriosclerosis and its complications].
    Nagornev VA; Mal'tseva SV; Seliverstova VG; Sokurenko GIu; Voskan'iants AN
    Arkh Patol; 2004; 66(2):52-60. PubMed ID: 15154386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
    Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ
    J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.